E. Long-Mira

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2020, medRxiv.

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer

C. Marquette, S. Leroy, J. Sabourin, 2017, Oncotarget.

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer

C. Marquette, P. Brest, J. Benzaquen, 2022, Clinical and translational medicine.

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients

A. Stenzinger, C. Marquette, J. Benzaquen, 2019, Cancers.

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

M. Mathieu, P. Rochaix, J. Selves, 2018, Cancers.

Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps

P. Vrignaud, A. Merino-Trigo, E. Selva, 2014, Cancer medicine.

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.

C. Marquette, J. Sabourin, P. Hofman, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

S. Leroy, P. Hofman, V. Hofman, 2019, Journal of thoracic disease.

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images

N. Ayache, C. Marquette, J. Benzaquen, 2022, Cancers.

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

A. Hofman, S. Cajal, P. Brousset, 2020, ESMO Open.

BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer

J. Merlio, J. Emile, H. Bégueret, 2014, Pathology.

In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAFV600E mutation status and together with hypoxia-related proteins predicts aggressive behavior

N. Guevara, A. Bozec, J. Santini, 2013, Virchows Archiv.

Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide

V. Richez, N. Cardot-Leccia, E. Long-Mira, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

Marius Ilie, Paul Hofman, Bernard Padovani, 2014, PloS one.

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC

P. Brousset, C. Marquette, J. Mazières, 2022, JTO clinical and research reports.

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma

Paul Hofman, Emmanuel Chamorey, Olivier Guérin, 2018, Cancers.

Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2022, Lung cancer.

Association of combined PD‐L1 expression and tumour‐infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma

P. Hofman, V. Hofman, J. Lacour, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma

E. Gilson, P. Hofman, V. Hofman, 2021, Oncoimmunology.

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

C. Marquette, P. Hofman, V. Hofman, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients

C. Marquette, D. Shames, E. Selva, 2017, Oncotarget.

Reflectance confocal microscopy features of acral lentiginous melanoma: a comparative study with acral nevi

L. Thomas, P. Bahadoran, E. Cinotti, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[In vivo reflectance confocal microscopy in Dubreuilh melanoma].

P. Bahadoran, J. Lacour, E. Long-Mira, 2014, Annales de dermatologie et de venereologie.

Use of high‐definition optical coherent tomography (HD‐OCT) for imaging of melanoma

P. Bahadoran, P. Hofman, J. Lacour, 2013, The British journal of dermatology.

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System

C. Marquette, J. Benzaquen, P. Hofman, 2021, Frontiers in Pharmacology.

A new reflectance confocal microscopy feature of photoaging: Nodular elastosis

P. Bahadoran, E. Long-Mira, T. Passeron, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples.

C. Marquette, J. Benzaquen, P. Hofman, 2023, Lung cancer.

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients.

P. Hofman, V. Hofman, Marame Hamila, 2018, Journal of visualized experiments : JoVE.

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer

P. Hofman, V. Hofman, E. Long-Mira, 2023, Journal of personalized medicine.

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

C. Marquette, J. Mazières, J. Sabourin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

C. Marquette, S. Leroy, J. Benzaquen, 2023, International journal of molecular sciences.

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)

L. Xerri, C. Marquette, J. Benzaquen, 2023, Journal of personalized medicine.

Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.

P. Bahadoran, G. Poissonnet, J. Emile, 2013, The Journal of investigative dermatology.

E. Long-Mira, M. Ilié, M. Poudenx, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Interest of high‐definition optical coherent tomography (HD‐OCT) for non‐invasive imaging of dermatofibroma: a pilot study

E. Long-Mira, A. Picard, Thierry Passeron, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non-Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging.

R. Schiappa, C. Bonnetaud, E. Long-Mira, 2024, The American journal of surgical pathology.